Document Detail

Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group.
MedLine Citation:
PMID:  11016449     Owner:  NLM     Status:  MEDLINE    
Type 1 diabetes is considered to be a T-cell-mediated autoimmune disease in which insulin-producing beta-cells are destroyed. Immunity to insulin has been suggested to be one of the primary autoimmune mechanisms leading to islet cell destruction. We have previously shown that the first immunization to insulin occurs by exposure to bovine insulin (BI) in cow's milk (CM) formula. In this study, we analyzed the development of insulin-specific T-cell responses by proliferation test, emergence of insulin-binding antibodies by enzyme immunoassay, and insulin autoantibodies by radioimmunoassay in relation to CM exposure and family history of type 1 diabetes in infants with a first-degree relative with type 1 diabetes and increased genetic risk for the disease. The infants were randomized to receive either an adapted CM-based formula or a hydrolyzed casein (HC)-based formula after breast-feeding for the first 6-8 months of life. At the age of 3 months, both cellular and humoral responses to BI were higher in infants exposed to CM formula than in infants fully breast-fed (P = 0.015 and P = 0.007). IgG antibodies to BI were higher in infants who received CM formula than in infants who received HC formula at 3 months of age (P = 0.01), but no difference in T-cell responses was seen between the groups. T-cell responses to BI at 9 months of age (P = 0.05) and to human insulin at 12 (P = 0.014) and 24 months of age (P = 0.009) as well as IgG antibodies to BI at 24 months of age (P = 0.05) were lower in children with a diabetic mother than in children with a diabetic father or a sibling, suggesting possible tolerization to insulin by maternal insulin therapy. The priming of insulin-specific humoral and T-cell immunity occurs in early infancy by dietary insulin, and this phenomenon is influenced by maternal type 1 diabetes.
J Paronen; M Knip; E Savilahti; S M Virtanen; J Ilonen; H K Akerblom; O Vaarala
Related Documents :
65509 - Aetiology of juvenile-onset diabetes. a prospective study.
1865079 - Islet cell surface antibodies by an elisa method in diabetic and nondiabetic patients.
21789219 - Effects of genetic variants in adcy5, gipr, gckr and vps13c on early impairment of gluc...
21274399 - Glucagon-like peptide-1 and-2 levels in children with diabetic ketoacidosis.
2221799 - Humoral immune abnormalities in diabetes mellitus.
12021109 - Prevalence of ica-12 and other autoantibodies in north indian patients with early-onset...
9228219 - Insulin inhibits tyrosinase activity and 5-s-cysteinyldopa formation in human melanoma ...
2951759 - Fc and c3b receptor expression of phagocytes in poorly controlled diabetic patients.
15132879 - Influence of weight loss and physical activity interventions upon muscle lipid content ...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Diabetes     Volume:  49     ISSN:  0012-1797     ISO Abbreviation:  Diabetes     Publication Date:  2000 Oct 
Date Detail:
Created Date:  2000-10-17     Completed Date:  2000-10-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0372763     Medline TA:  Diabetes     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1657-65     Citation Subset:  AIM; IM    
Hospital for Children and Adolescents, University of Helsinki, Finland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibody Formation
Autoantibodies / blood
Diabetes Mellitus, Type 1 / genetics,  immunology*
Genetic Predisposition to Disease*
Immunity, Cellular
Immunoenzyme Techniques
Infant Food
Insulin / administration & dosage,  immunology*
T-Lymphocytes / immunology
Reg. No./Substance:
0/Autoantibodies; 0/Caseins; 11061-68-0/Insulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport ...
Next Document:  Anti-CD154 (CD40L) prevents recurrence of diabetes in islet isografts in the DR-BB rat.